Articles dans des revues avec comité de lecture (149)
  1. 9. Plant, E., Bellefroid, M., & Van Lint, C. (2023). A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation. Retrovirology, 20(1). doi:10.1186/s12977-023-00623-w
  2. 10. Chatterjee, D., Zhang, Y., Ngassaki-Yoka, C.-D., Dutilleul, A., Khalil, S., Hernalsteens, O., Wiche Salinas, T. R., Dias, J., Huicheng, C., Smail, Y., Goulet, J.-P., Brendan, B., Routy, J.-P., Van Lint, C., & Ancuta, P. (2023). Identification of Aryl Hydrocarbon Receptor as a Barrier to HIV-1 Infection and Outgrowth in CD4+ T-Cells (C. Van Lint and P. Ancuta are co-corresponding authors). Cell reports, 42(6), doi:10.1016/j.celrep.2023.112634, 112634.
  3. 11. Pasternak, A. A., Rohr, O., Van Lint, C., & Kula-Pacurar, A. (2023). Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency. Frontiers in Cellular and Infection Microbiology, 13, 1213356. doi:10.3389/fcimb.2023.1190867
  4. 12. Pasquereau, S., Galais, M., Bellefroid, M., Pachón Angona, I., Morot-Bizot, S., Ismaili, L., Van Lint, C., & Herbein, G. (2022). Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro. (C. Van Lint and G.Herbein are co-senior authors, equal contribution). Scientific reports, 12(1), 20309. doi:10.1038/s41598-022-24682-9
  5. 13. Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022). Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. EBioMedicine, 79, 103985. doi:10.1016/j.ebiom.2022.103985
  6. 14. Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Tjalsma, S., Nestola, L., Plant, E., Vos, E., Cristinelli, S. S., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Burny, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic acids research, 50(6), 3190-3202. doi:10.1093/nar/gkac107
  7. 15. Rodari, A., Darcis, G., & Van Lint, C. (2021). The Current Status of Latency Reversing Agents for HIV-1 Remission. Annual review of virology, 8(1), 491-514. doi:10.1146/annurev-virology-091919-103029
  8. 16. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology., 101478. doi:10.1016/j.smim.2021.101478
  9. 17. Hamann, M. M., Ehmele, P., Verdikt, R., Bialek-Waldmann, J. J., Virdi, S., Günther, T., Van Lint, C., Grundhoff, A., Hauber, J., & Lange, U. C. (2021). Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene. Virus research, 293, 198260. doi:10.1016/j.virusres.2020.198260
  10. 18. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology, 51, 101478. doi:10.1016/j.smim.2021.101478
  11. 19. Ait-Ammar, A., Bellefroid, M., Daouad, F., Martinelli, V., Van Assche, J., Wallet, C., Rodari, A., De Rovere, M., Fahrenkrog, B., Schwartz, C., Van Lint, C., Gautier, V., & Rohr, O. (2021). Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage (C. Van Lint, V. Gautier and O. Rohr are co-last authors, equal contribution). Scientific reports, 11(1), 2692. doi:10.1038/s41598-021-82164-w
  12. 20. Verdikt, R., Hernalsteens, O., & Van Lint, C. (2021). Epigenetic mechanisms of hiv-1 persistence. Vaccines, 9(5), 514. doi:10.3390/vaccines9050514
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>